Chi-Keung Cheng

Chi-Keung Cheng

Blood Cancer Cytogenetics and Genomics Laboratory, The Chinese University of Hong Kong

Affiliated withThe Chinese University of Hong Kong

Research Area

Biography

Dr. Cheng received his undergraduate degree (first class honors) and M.Phil. from the University of Hong Kong, and a Ph.D. from the University of British Columbia, Canada. He is currently in charge of the Molecular Hematology services in the Prince of Wales Hospital, Hong Kong. Dr. Cheng is also an Adjunct Associate Professor of the Department of Anatomical & Cellular Pathology, The Chinese University of Hong Kong. His main research focuses on the identification and molecular characterization of novel genetic/epigenetic aberrations in acute myeloid leukemia, a lethal blood cancer in adults and children. His work has been published in Blood, Haematologica and Molecular Cancer.

JoVE Journal Publications

ArticleTotal : 1
Year
Investigation of the Transcriptional Role of a <em>RUNX1</em> Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Publication title

Cited by 3

2019

Other Publications

Article
Year
Transcriptional repression of the RUNX3/AML2 gene by the t(8;21) and inv(16) fusion proteins in acute myeloid leukemia.

Blood| PubMed ID: 18663147

2008
2011
2013
2013
2012
2013
2013
2013
2015
2015
2016
2017
Distinctive regional-specific PROS1 mutation spectrum in Southern China.

Journal of thrombosis and thrombolysis| PubMed ID: 29748776

2018
2018
2018
2018